Anthropic debuts AI-driven pharma R&D tool, Claude Science - Pharmaceutical Technology

2 sources7 storiesFirst seen 7/1/2026Score53Mixed Progress

Bigness

Coverage

Recency

Engagement

Velocity

100

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive0%

Neutral100%

Negative0%

Geography

North AmericaEurope

Expert Signals

Anthropic - Google News

source • 6 mentions

MIT Technology Review - AI

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Anthropic launches AI initiative for life sciences - medwatch.com.

Supported by 2 stories

Anthropic launches Claude Science AI workbench for researchers - qz.com.

Supported by 2 stories

The Download: Anthropic launches Claude Science, and California's carbon manure math - MIT Technology Review.

Supported by 2 stories

Anthropic launches Claude Sonnet 5 for cheaper AI agent tasks - qz.com.

Supported by 2 stories

Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI - Benzinga.

Supported by 2 stories

The Download: Anthropic launches Claude Science, and California's carbon manure math.

Supported by 1 story

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

Supported by 1 story

Claude Science is Anthropic's newest flagship product At an event for pharmaceutical executives, biotech founders, and researchers yesterday, Anthropic announced Claude Science, a major new product intended to support scientific research…

Supported by 1 story

Summary

Summary: Anthropic has launched a new AI-driven pharmaceutical research and development (R&D) tool called Claude Science. Why It Matters: This marks another significant step for Anthropic, demonstrating their commitment to using artificial intelligence in drug discovery. The tool aims to make the process more efficient and accessible, potentially revolutionizing the way